Gujarat Themis Biosyn Limited Incorporates Stepdown Subsidiary in Ireland

Gujarat Themis Biosyn Limited Incorporates Stepdown Subsidiary in Ireland

Gujarat Themis Biosyn Limited Incorporates Stepdown Subsidiary in Ireland​

Gujarat Themis Biosyn Limited has completed the incorporation of a stepdown subsidiary company in Ireland, marked by the establishment of Themis Biosyn Private Limited. This move signifies an expansion of the company's international presence within the pharmaceutical industry.

The new entity, incorporated on June 16, 2026, is set up as a wholly owned subsidiary of Gujarat Themis Biosyn Limited. The purpose of this incorporation aligns with the company's operational objectives in the global market.

Details regarding the newly incorporated subsidiary have been confirmed, including its industry classification and structure.

DetailSpecification
Subsidiary NameThemis Biosyn Private Limited
Country of IncorporationIreland
IndustryPharmaceutical Industry
Date of IncorporationJune 16, 2026
Share Capital100 Euro
Control Achieved100% of the shareholding

The entity being acquired holds a substantial stake in Themis Biosyn Private Limited. Gujarat Themis Biosyn Limited maintains full control over the new subsidiary, which operates under the banner of Themis Biosyn Ireland Private Limited. This structure establishes a dedicated operational foothold for the company in the international market.

HUDCO Stock Price Movement​

On Wednesday, shares of Housing & Urban Development Corporation Limited edged higher to close at ₹213.65, rising 0.08% from the previous session. The stock traded within a range defined by ₹213.00 and ₹216.88 during the trading period, logging a total volume of 2.81 million shares.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Last edited by a moderator:
Back
Top